Updated Jul 16, 2026
Belldegrun Arie has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Arie Belldegrun is a prominent figure in the biotechnology sector, known for his leadership roles in companies like UroGen Pharma Ltd. and Kronos Bio, Inc. He has a strong background in oncology and has contributed to the development of innovative cancer therapies.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-06-20 | KRON | Kronos Bio, Inc. | J — Other acquisition / disposition | 679.6K | $0.57 | $387K |
| 2025-06-20 | KRON | Kronos Bio, Inc. | J — Other acquisition / disposition | 2.77M | $0.57 | $1.58M |
Arie Belldegrun is a prominent figure in the biotechnology sector, known for his leadership roles in companies like UroGen Pharma Ltd. and Kronos Bio, Inc. He has a strong background in oncology and has contributed to the development of innovative cancer therapies.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Belldegrun Arie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.